{"organizations": [], "uuid": "a3670e94efd9613d4798c24c756cf5f225754d9c", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.cbs8.com", "main_image": "", "site_section": "http://www.cbs8.com/category/266385/technology-general", "section_title": "Technology Press Releases from PRWeb - CBS News 8 - San Diego, CA News Station - KFMB Channel 8", "url": "http://www.cbs8.com/story/30347090/small-molecules-drug-design-and-novel-inhibitors-at-the-15th-annual-advances-and-progress-in-drug-design-conference", "country": "US", "title": "Small Molecules Drug Design and Novel Inhibitors at the 15th Annual Advances and Progress in Drug Design Conference", "performance_score": 0, "site": "cbs8.com", "participants_count": 1, "title_full": "Small Molecules Drug Design and Novel Inhibitors at the 15th Annual Advances and Progress in Drug Design Conference - CBS News 8 - San Diego, CA News Station - KFMB Channel 8", "spam_score": 0.0, "site_type": "news", "published": "2015-10-26T12:11:00.000+02:00", "replies_count": 0, "uuid": "a3670e94efd9613d4798c24c756cf5f225754d9c"}, "author": "cbs8", "url": "http://www.cbs8.com/story/30347090/small-molecules-drug-design-and-novel-inhibitors-at-the-15th-annual-advances-and-progress-in-drug-design-conference", "ord_in_thread": 0, "title": "Small Molecules Drug Design and Novel Inhibitors at the 15th Annual Advances and Progress in Drug Design Conference", "locations": [], "entities": {"persons": [], "locations": [], "organizations": []}, "highlightText": "", "language": "english", "persons": [], "text": "Returning for its 15th year and following on from the major success of previous events, SMi is proud to announce that the Advances and Progress in Drug Design conference will take place on 15th-16th February 2016 in London, UK.\nLondon, United Kingdom (PRWEB UK) 26 October 2015\nThis year’s event will focus on enabling biophysical tools and highlight key advancements in protein-based drug discovery, with new areas of discussion including: Small molecules in drug design - A look at novel inhibitors and favourable protein-fragment interactions. It will take a closer look at combined HTS and FBDD methods for lead generation and the application of biophysical methods such as: X-Ray Crystallography, NMR, Biocore and ITC to aid the prioritisation of target inhibitors.\nConference program will include interactive presentations, case studies and keynote addresses which will enable attendees to gain new insights in organised dynamic structures on a 3D project database using novel algorithms to determine specific subunits, as well as understand data mining workflows and the IMI Open PHACTS projects.\nPlus, two interactive half-day post-conference workshops will be presented by Barcelona University: A fresh view on molecular recognition: the dynamic perspective; and C4X Discovery: Analysis and Application of Ligand Conformation in Drug Design.\nConfirmed Sponsors for 2016: Chemical Computing Group and Openeye Scientific Software\nChair for 2016:\nGregg Seigal, Chief Executive Officer, ZoBio\nFeatured Speakers:\nDoug Johnson, Research Fellow, Pfizer Tove Sjögren, Associate Director, AstraZeneca Herman van Vlijmen, Senior Director, Janssen Paul Hawkins, Applications Science Group Leader, Open Eye Scientific Software Armin Ruf, Section Head, Biostructure, Roche Gianni Chessari, Director, Astex Pharmaceuticals Hans Matter, Senior Scientist, Sanofi-Aventis, and many more\nThose who are interested in attending are advised to register before 30th October to secure the place at the conference and save £400.\nFor the full event agenda/ to register please visit: http://www.drug-design.co.uk/prweb\nEND", "external_links": ["http://www.drug-design.co.uk/prweb"], "published": "2015-10-26T12:11:00.000+02:00", "crawled": "2015-10-26T12:33:38.229+02:00", "highlightTitle": ""}